IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC Felip, E., Wakelee, H., Vallieres, E., Zhou, C., Zuo, Y., Xia, F., Sandler, A., Altorki, N. ELSEVIER SCIENCE INC. 2017: S2398–S2399

View details for DOI 10.1016/j.jtho.2017.11.017

View details for Web of Science ID 000463860802553